1,2-Dipalmitoylphosphatidylcholine
"1,2-Dipalmitoylphosphatidylcholine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS.
MeSH Number(s)
D10.570.755.375.760.400.800.224
Concept/Terms
1,2-Dipalmitoylphosphatidylcholine- 1,2-Dipalmitoylphosphatidylcholine
- 1,2 Dipalmitoylphosphatidylcholine
- 1,2-Dipalmitoyl-Glycerophosphocholine
- 1,2 Dipalmitoyl Glycerophosphocholine
- Dipalmitoyl Phosphatidylcholine
- Phosphatidylcholine, Dipalmitoyl
- Dipalmitoylglycerophosphocholine
- Dipalmitoyllecithin
- 1,2-Dihexadecyl-sn-Glycerophosphocholine
- 1,2 Dihexadecyl sn Glycerophosphocholine
- Dipalmitoylphosphatidylcholine
Below are MeSH descriptors whose meaning is more general than "1,2-Dipalmitoylphosphatidylcholine".
Below are MeSH descriptors whose meaning is more specific than "1,2-Dipalmitoylphosphatidylcholine".
This graph shows the total number of publications written about "1,2-Dipalmitoylphosphatidylcholine" by people in Harvard Catalyst Profiles by year, and whether "1,2-Dipalmitoylphosphatidylcholine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 2 | 2 |
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 1 | 3 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 4 | 4 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
Below are the most recent publications written about "1,2-Dipalmitoylphosphatidylcholine" by people in Profiles.
-
Liposome interaction with macrophages and foam cells for atherosclerosis treatment: effects of size, surface charge and lipid composition. Nanotechnology. 2021 Oct 07; 32(50).
-
Investigating Substrate Analogues for Mycobacterial MenJ: Truncated and Partially Saturated Menaquinones. Biochemistry. 2019 03 26; 58(12):1596-1615.
-
Structure Dependence of Pyridine and Benzene Derivatives on Interactions with Model Membranes. Langmuir. 2018 07 31; 34(30):8939-8951.
-
Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes. ACS Infect Dis. 2017 08 11; 3(8):606-619.
-
Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity. Ann Rheum Dis. 2017 Mar; 76(3):602-611.
-
Iron Ion and Iron Hydroxide Adsorption to Charge-Neutral Phosphatidylcholine Templates. Langmuir. 2016 08 02; 32(30):7664-70.
-
Effects of nickel-oxide nanoparticle pre-exposure dispersion status on bioactivity in the mouse lung. Nanotoxicology. 2016; 10(2):151-61.
-
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases. Sci Rep. 2014 Nov 18; 4:7085.
-
Nature of the charged headgroup determines the fusogenic potential and membrane properties of lithocholic acid phospholipids. J Phys Chem B. 2014 Aug 07; 118(31):9341-8.
-
Fluorescence (fluidity/hydration) and calorimetric studies of interactions of bile acid-drug conjugates with model membranes. J Phys Chem B. 2013 Feb 21; 117(7):2123-33.